Healthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500. Yet, many leading healthcare companies just issued better-than-expected financial results for this year’s first quarter.Additionally, these stocks tend to perform well during presidential election years. Why? Healthcare is often an issue for candidates on the campaign trail.Many analysts expect healthcare stocks to outperform going forward, espe ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the past month, shares of this maker of infant formula, medical devices and drugs have returned -5.4%, compared to the Zacks S&P 500 composite's -4.1% change. During this period, the Zacks Medical - Products industry, which Abbott falls in, has lost 3.6%. The key question now is: What could be the stock's future d ...

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revi ...

More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ BTK Everolimus Eluting Resorbable Scaffold dissolves over time after it has opened blocked arteries below the knee (BTK) The Esprit BTK System is a dissolving stent that offers the possibility of better outcomes for people with the most severe form of PAD ABBOTT PARK, Ill., April 29, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that ...

An exhibit from Abbott is seen at the Las Vegas Convention Center during the Consumer Electronics ... [+] Show January 10, 2024, in Las Vegas, Nevada. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)AFP via Getty ImagesAbbott (NYSE: ABT) recently reported its Q1 results, with revenues above and earnings exceeding our expectations. The company reported revenue of $10 billion and earnings of $0.98 on a per-share and adjusted basis, compared to our estimates of $9.9 billio ...

Key TakeawaysAbbott Laboratories stock fell in intraday trading Wednesday as investors reacted to a first-quarter earnings report that beat expectations, but included current-quarter adjusted earnings per share (EPS) guidance mostly below estimates.Lower demand for COVID testing dragged down sales in Abbott's diagnostics division by 17.6% compared to the prior-year quarter.Medical devices posted a 14.2% sales increase from Q1 2023, the biggest percentage gain among company units. Shares of Abbott Laboratori ...

Abbott Laboratories (NYSE:ABT) Q1 2024 Results Conference Call April 17, 2024 9:00 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Phil Boudreau - Senior Vice President, Finance and Chief Financial Officer Bob Funck - Executive Vice President, Finance Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Josh Jennings - Cowen Travis Steed - BofA Securities Vijay Kumar - Evercore, ISI Joanne Wuensch ...

Pre-market futures are up slightly at this hour. Markets look to rebound off a three-day losing streak on the S&P 500 and Nasdaq; the blue-chip Dow outperformed the field yesterday, closing +0.17%. Major indices are all lower over the past month, from -1.7% (tech-heavy Nasdaq) to -2.9% (small-cap Russell 2000). Year to date, only the Russell is back in the red — the Dow is +0.3%, the S&P is +6.7% and the Nasdaq is +7.2%. Late March highs — including all-time S&P levels — have given way to profit-taking and ...

Wednesday, April 17th, 2024Pre-market futures are up slightly at this hour. Markets look to rebound off a three-day losing streak on the S&P 500 and Nasdaq; the blue-chip Dow outperformed the field yesterday, closing +0.17%. Major indices are all lower over the past month, from -1.7% (tech-heavy Nasdaq) to -2.9% (small-cap Russell 2000). Year to date, only the Russell is back in the red — the Dow is +0.3%, the S&P is +6.7% and the Nasdaq is +7.2%. Late March highs — including all-time S&P levels — have give ...

Abbott Laboratories (ABT) reported first-quarter 2024 adjusted earnings per share (EPS) of 98 cents, which topped the Zacks Consensus Estimate by 2.1%. However, the adjusted figure decreased 4.9% from the prior-year quarter’s level. The quarter’s adjustments include 28 cents of certain non-recurring items.GAAP EPS came in at 70 cents, down 6.7% year over year.First-quarter worldwide sales of $9.96 billion were up 2.2% year over year on a reported basis. The top line exceeded the Zacks Consensus Estimate by ...